Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
CBT124
BIOLOGICAL
2 trials
Sponsors
Cipla BioTec Pvt. Ltd.
Conditions
Healthy
Non-Small Cell Lung Carcinoma
Phase 1
PK Bioequivalence Single-dose Safety Tolerability Study in Healthy Male Volunteers to Compare CBT124 & Avastin(EU&US)
NCT02747823
Cipla BioTec Pvt. Ltd.
Healthy
Start: 2016-06-30
End: 2016-12-31
Target: 150
Updated: 2016-09-19
Phase 3
Efficacy-Safety-Immunogenicity Study of CBT124&EU-sourced Avastin® in Stage 4 NSCLC
NCT02879097
Cipla BioTec Pvt. Ltd.
Non-Small Cell Lung Carcinoma
Start: 2016-12-31
End: 2018-05-31
Target: 200
Updated: 2016-08-25